Exact Sciences Announces Medicare Coverage for Oncodetect Molecular Residual Disease Test in Colorectal Cancer
| RYBOX Fund | USD 56.14 0.23 0.41% |
Slightly above 54% of Biotechnology Fund's investor base is interested to short. The analysis of overall sentiment of trading Biotechnology Fund Class mutual fund suggests that many investors are impartial at this time. Biotechnology Fund's investing sentiment can be driven by a variety of factors including economic data, Biotechnology Fund's earnings reports, geopolitical events, and overall market trends.
Biotechnology |
MADISON, Wis., July 09, 2025--Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, today announced that its Oncodetect molecular residual disease test has received Medicare coverage through the Centers for Medicare Medicaid Services Molecular Diagnostic Services Program for serial use in patients with stage II, III and resectable stage IV colorectal cancer in the adjuvant and recurrence monitoring settings over a five-yea
Read at finance.yahoo.com
 |
Biotechnology Fund Fundamental Analysis
We analyze Biotechnology Fund's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotechnology Fund using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotechnology Fund based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Minimum Initial Investment
Minimum Initial Investment Comparative Analysis
Biotechnology Fund is currently under evaluation in minimum initial investment among similar funds. Minimum Initial Investment refers to minimum amount the fund family or category will require an investor to deposit to acquire the very first position in the fund or to open an account. In other words, Minimum Initial Investment is a guarantee that any investment from a purchaser of a fund meets the minimum requirement of the fund.
Biotechnology Fund Class Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biotechnology Fund mutual fund to make a market-neutral strategy. Peer analysis of Biotechnology Fund could also be used in its relative valuation, which is a method of valuing Biotechnology Fund by comparing valuation metrics with similar companies.
Peers
Biotechnology Fund Related Equities
| IGIEX | Ashmore Emerging | 0.23 | ||||
| SEDAX | Siit Emerging | 0.22 | ||||
| FGWMX | Fidelity New | 0.08 | ||||
| MKDCX | Blackrock Emerging | 1.31 | ||||
| QNZIX | Aqr Sustainable | 2.25 |
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |